Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation [7]

Bone Marrow Transplantation

Volumn 35, Issue 4, 2005, Pages 427-428

  Herr, A L ^a   Hatami, A ^a   Kokta, V ^a   Dalle, J H ^a   Champagne, M A ^a   Duval, M ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETOPOSIDE; IMATINIB; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LABETALOL; METHYLPREDNISOLONE; PREDNISONE; RABBIT ANTISERUM; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; BACTERIAL SUPERINFECTION; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; PEMPHIGUS FOLIACEUS; PHILADELPHIA 1 CHROMOSOME; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN BIOPSY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 14644392262     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704808     Document Type: Letter

References (10)

1. Szabolcs P, Reese M, Yancey KB et al. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 30: 327-329.
2. Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873-881.
3. Burger J, Gmur J, Brucknerb-Tuderman L. Epidermolysis bullosa acquisita, a rare complication of allogeneic bone marrow transplantation? Bone Marrow Transplant 1992; 9: 139-141.
4. Delbado C, Rieckoff Cantoni L, Helg C et al. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 377-379.
5. Heizmann M, Itin P, Wernli M et al. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001; 66: 142-144.
6. Goebeler M, Herzog S, Bröcker EB, Zillikens D. Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab. Br J Dermatol 2003; 149: 899-901.
7. Edwards JC, Szczepanski L, Szechinski J et al. Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. New Engl J Med 2004; 350: 2572-2581.
8. Raj A, Bertolone S, Cheerva A. Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 2004; 26: 312-314.
9. Maschan AA, Skorobogatova EV, Balashow DN et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002; 30: 405-407.
10. Canninga-van Dijk M, Van der Straaten HM, Fijnheer R et al. Anti-CD20 monoclonal antibody treatment in six patients with therapy-refractory chronic graft-versus-host disease. Blood 2004; 104: 2603-2606.